Ghost Tree Capital’s Karuna Therapeutics KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-12,500
Closed -$2.11M – 84
2023
Q3
$2.11M Hold
12,500
– – 0.7% 46
2023
Q2
$2.71M Sell
12,500
-5,000
-29% -$1.07M 0.89% 29
2023
Q1
$3.18M Sell
17,500
-22,500
-56% -$4.3M 0.94% 36
2022
Q4
$7.86M Buy
40,000
+10,000
+33% +$2.14M 3.36% 13
2022
Q3
$6.75M Sell
30,000
-15,000
-33% -$3.04M 1.89% 20
2022
Q2
$5.69M Sell
45,000
-15,000
-25% -$1.72M 2.97% 14
2022
Q1
$7.61M Buy
+60,000
New +$6.76M 1.65% 11

Other funds holding KRTX

Ghost Tree Capital's KRTX Position: Q4 2023 in Review

Ghost Tree Capital sold out of Karuna Therapeutics (KRTX) in Q4 2023, closing a stake of 12,500 shares — an estimated $2.11M sold.

Ghost Tree Capital first reported a position in KRTX in Q1 2022 and held it in 7 quarters. The position peaked at $7.86M in Q4 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Ghost Tree Capital reported no remaining Karuna Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 12,500 Karuna Therapeutics shares in Q4 2023, an estimated $2.11M.
  • Ghost Tree Capital first reported a position in Karuna Therapeutics in Q1 2022 and held it in 7 quarters.
  • Ghost Tree Capital's Karuna Therapeutics position peaked at $7.86M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics as of Q4 2023.

Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.